Lophius Biosciences Closes Financing Round and Appoints
Lophius Biosciences, a developer of T-cell-based diagnostic test systems, has closed a further financing round. VRD GmbH, WIC GmbH and existing investors such as S-Refit, HighTech Gründerfonds, Bayern Kapital and two business angels have backed the business. Prof. Dr. Ralf Wagner, former CEO of GeneArt AG, has been appointed as managing director to drive the further development of the company with the current managing director Dr. Michael Lutz.
22 January 2013•3 mins read
